Ekaterina Alexeeva (E I Alexeeva)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Extracorporeal Membrane Oxygenation

Coronavirus Disease

Juvenile Idiopathic Arthritis

Placebo Controlled

Top Venues

Terapevticheskii arkhiv

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hermine I Brunner, César Pacheco-Tena, Ingrid Louw, Gabriel Vega-Cornejo, Ekaterina Alexeeva, Simone Appenzeller, Vyacheslav Chasnyk, Thomas Griffin, Carmen Navarrete Suarez, Sheila Knupp-Oliveira, Andrew Zeft, Yonatan Butbul Aviel, Deirdre De Ranieri, Beth S Gottlieb, Deborah M Levy, C Egla Rabinovich, Clóvis Artur Silva, Yury Spivakovsky, Yosef Uziel, Sarah Ringold, Xie L Xu, Jocelyn H Leu, Edwin Lam, Yuhua Wang, Daniel J Lovell, Alberto Martini, Nicolino Ruperto, null null
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label, Phase III Study. The Journal of rheumatology (2024)
Sergey N Avdeev, Vladimir P Chulanov, Ekaterina Alexeeva, O A Aleshina, A V Bereznikov, O N Kotenko, Alexander M Lila, Zinaida Yu Mutovina, Elena N Parovichnikova, Darya S Fomina, N F Frolova, A O Shevchenko
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic]. Terapevticheskii arkhiv 95 (8) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
Sergey N Avdeev, Vladimir P Chulanov, Ekaterina Alexeeva, O A Aleshina, A V Bereznikov, O N Kotenko, Alexander M Lila, Zinaida Yu Mutovina, Elena N Parovichnikova, Darya S Fomina, N F Frolova, A O Shevchenko
[The burden of COVID-19 in a heterogeneous population of immunocompromised patients - realities of the postpandemic]. Terapevticheskii arkhiv 95 (8) (2023)
M S Lebedkina, Darya S Fomina, Zinaida Yu Mutovina, U A Mаrkina, P O Bogomolov, Vladimir P Chulanov, Mar'yana A Lysenko, Ekaterina Alexeeva
[Use of a combination of the virus-neutralizing monoclonal antibodies casirivimab and imdevimab for mild to moderate COVID-19 in patients at high risk of progression: Results of the non-interventional observational study]. Terapevticheskii arkhiv 95 (6) (2023)
U A Mаrkina, Darya S Fomina, M S Lebedkina, Tat'yana S Kruglova, Anton A Chernov, A I Zagrebneva, Zinaida Yu Mutovina, Alexander V Karaulov, Ekaterina Alexeeva, Mar'yana A Lysenko
[Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit]. Terapevticheskii arkhiv 94 (5) (2022)